ProfileGDS5678 / 1425872_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 6% 7% 6% 6% 6% 19% 9% 7% 10% 7% 6% 6% 8% 6% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 12.153576
GSM967853U87-EV human glioblastoma xenograft - Control 22.137247
GSM967854U87-EV human glioblastoma xenograft - Control 32.1376
GSM967855U87-EV human glioblastoma xenograft - Control 42.091666
GSM967856U87-EV human glioblastoma xenograft - Control 52.091726
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 12.512919
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 22.233989
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 32.118967
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 42.2223710
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 12.12647
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 22.122126
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 32.108776
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 42.188328
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 52.127056